Our expertise lies in assisting clients who are seeking additional commercial expertise to transform their innovation pipeline into investible structures within the fields of Medtech and software.

At the IDC we understand the unique challenges faced by organisations operating in these cutting-edge sectors. Alongside our clinical and regulatory advisory, we recognise the importance of securing the necessary resources to fuel growth, drive innovation, and make a meaningful impact on society. That's why we dedicate ourselves to helping our clients navigate the complex landscape of capital sourcing and funding strategies, ensuring they have the financial support needed to bring their game-changing innovations to market.

Our team of experienced professionals possesses a deep understanding of the healthcare, technology, and investment landscapes. Leveraging our expertise, we work closely with our clients to develop tailored strategies that align with their goals, vision, and market dynamics. Whether you're a healthcare trust looking to finance ground-breaking medical advancements or a charity seeking capital for impactful initiatives, we're here to guide you every step of the way.

Our experienced Healthcare Solutions consultants have a passion for enabling new models of healthcare that deliver better clinical and economic value – improving both healthcare safety and efficiency deployed in a way that doesn’t leave anyone behind. 

With expertise supporting new product launches and program expansions, our team will work closely with you to define and develop strategy. We employ our deep domain experience to envision old problems in new ways to help avoid potential pitfalls and take advantage of the most appropriate development, approval and procurement pathways.

The best medical innovation emerges from clinicians facing problems and looking for practical solutions day-in-day-out. However, the perspective taken is often solely clinical or academic in nature, failing to appreciate how to generate sufficient interest and necessary funding to create an effective, approved, scalable and commercial product.

We work with innovators, from early-stage ideas to creation of business cases to incorporate health economics, development costs, regulatory considerations, market size and positioning, funding routes and procurement pathways. These will then form the basis of how we take innovations to our investor community and establish the business to bring a successful product to market and manage all distribution and post-market support.

Understanding the regulatory pathway for a new medical device or combination product can be confusing. Our regulatory experts provide guidance and recommendations for classifying your device, while considering the intended use, technology, regulatory landscape, and commercialization strategy. Through this assessment we can ensure that the output of our design and development process will result in a complete package for regulatory submission.

We have experience of working with all classes of medical device (Class I, IIa, IIb and III) across a wide range of product types. In addition, Software as a Medical Device (SaMD) is a specialism as we have helped numerous clients classify the device (under Rule 11 of the new Medical Device Regulation) and prepare the relevant documentation to ensure compliance with the new MDR, IEC 62304 and ISO 27001.

Much of our testing activity occurs before Clinical Trials, to aid the design and development to move from an initial concept or prototype to a robust evaluation of verification that the device will, indeed, meet the intended use and meet user requirements. 

Clinical data does not stop once regulatory approval has been met and your device is in-market. We can also support the collection of surveillance data to ensure continued safety and effectiveness and inform further innovation roadmap.

As an IDC innovation or product reaches its final stages, it becomes equally important to present it creatively and appropriately to engage the desired audience. This is where design and branding can play a crucial role, helping to sell the new idea in a style that captivates the buyer or end user. Ultimately, it’s about confidence and creating an image for the innovation/project that all stakeholders can be proud of. Hence, at the IDC, we take this part of the process seriously and always offer branding as part of our service suite.

Creative outputs may be as simple as a brand identifier in the form of a logo, a more granular investor presentation, packaging solutions, explainer videos / animations and more. Whether these solutions are part of the development phase or designed to go to market – the IDC is focused on guiding all branding and design.

It is crucial to have the academic and clinical expertise formally partner with a commercially experienced team to manage this process and any other merger or acquisition activities. The IDC's expertise in navigating the intricacies of the market ensures that the innovations not only benefit patient care but also generate substantial returns for the stakeholders. By leveraging the IDC's knowledge and resources, the accelerator can maximize the potential of these innovations, fostering advancements in healthcare and creating a sustainable ecosystem of progress.